New oral anticoagulants to revolutionise venous thromboembolism (VTE) management
To access this article, please choose from the options below
PII: S1361-3111(09)00175-7
doi:10.1016/j.joon.2009.08.002
© 2009 Elsevier Ltd. All rights reserved.
PII: S1361-3111(09)00175-7
doi:10.1016/j.joon.2009.08.002
© 2009 Elsevier Ltd. All rights reserved.